期刊文献+

中重度卵巢过度刺激综合征临床特点及治疗 被引量:1

Clinical Analysis of 35 Cases on Moderate and Severe Ovarian Hyperstimulation Syndrome (OHSS)
下载PDF
导出
摘要 目的:探讨中重度卵巢过度刺激综合征的临床特点及治疗、预防的方法。方法:回顾性分析我院生殖中心自2007-06~2009-06发生的35例中重度卵巢过度刺激综合征的临床资料。结果:在500个超排卵周期中有35例发生中重度卵巢过度刺激综合征(发生率为7%),临床表现为腹痛、腹胀、恶心、呕吐、体重增加,重度出现胸水、腹水、呼吸困难、血液浓缩,卵巢增大等,经综合治疗,均缓解好转出院,无1例终止妊娠。结论:在实施药物超促排卵过程中要坚持个体化方案,及早预防,对中重度患者严密观察、合理治疗。 Objective:To investigate the characteristics,treatment and prevention of ovarian hyperstimulation syndrome (OHSS).Methods:From June 2007 to June 2009,35 cases of moderate and severe OHSS inpatients were retrospectively analyzed in the Reproductive Center of the 174th hospital of People's Liberation Army.Results:There were 35 moderate and severe OHSS cycles in 500 controlled ovarian super-stimulation cycles,the incident rate was 7%.The main clinical manifestations included abdominal pain、abdominal distension、nausea、weight gain,even hydrothorax 、ascites、dyspnoea、hemoconcentration、increased volume of ovarian,and so on.After the comprehensive therapy,all of them cured,no pregnancy was terminated.Conclusions:Individualization dosage regimen should be taken into the controlled ovarian hyperstimulation (COH) with drugs.The OHSS should be prevented,and the moderate and severe patients should be closely observed and rationally cured.
机构地区 解放军第
出处 《航空航天医药》 2010年第7期1102-1103,共2页 Aerospace Medicine
关键词 卵巢过度刺激综合征 控制性超促排卵 治疗 预防 Ovarian Hyperstimulation Syndrome (OHSS) The controlled ovarian hyperstimulation (COH) Treatment Precaution
  • 相关文献

参考文献4

二级参考文献35

  • 1黄惠娟,何春妮,宋岩峰.产后卵巢过度刺激综合征一例[J].中华妇产科杂志,2003,38(3):191-191. 被引量:7
  • 2Cobo AC, Requena A, Neuspiller F, et al. Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size. Hum Reprod, 1999,14(7): 1 864-8.
  • 3Cha KY, Hah SY, Chung HM, et al. Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. Fertil Steril, 2000,73(5): 978-83.
  • 4Mikkelsen AL & Lindenberg S. Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. Reproduction,2001,122(2): 587-92.
  • 5Pincus G & Enzmann EV. The comparative behavior of mammalian eggs in vivo and in vitro. The activation of ovarian eggs. J Exp Med, 1935,62: 665.
  • 6Edwards RG, Wales DS & Edin PH. Maturation in vitro of human ovarian oocytes. Lancet, 1965,1: 926.
  • 7Veeck LL, Wortham JW Jr, Witmyer J, et al. Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization. Fertil Steril, 1983,39(2): 594.
  • 8Cha KY, Choi DH, Koo J J, et al. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycle: their culture in vitro and their transfer in a donor oocyts program. Fertil Steril, 1991,55(1): 109-13.
  • 9Son WY, Yoon SH, Lee SW, et al. Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstimulated patients with PCOS after in-vivo hCG priming:case report. Hum Reprod, 2002,17(1):134-6.
  • 10Roberts R, Franks S & Hardy K. Culture environment modulates maturation and metabolism of human oocytes. Hum Reprod, 2002,17(11):2 950-6.

共引文献24

同被引文献14

  • 1SIMONI M, TEMPFER CB, DESTENAVES B, et al. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response[J]. Hum Reprod Update, 2008, 14(5): 459-484.
  • 2ULLOA-AGUIRRE A, ZARIEN T, PASAPERA AM, et al. Multiple facets of follicle-stimulating hormone receptor function [J]. Endocrine, 2007, 324(3): 251-263.
  • 3LUSSIANA C, GUANI B, MARI C, et al. Mutations and poly- morphisms of the FSH receptor(FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene[J]. Obstet Gynecol Surv, 2008, 63(12): 785-795.
  • 4ACHREKAR SK, MODI DN, DESAI SK, et al. Follicle-stimulat- ing hormone receptor polymorphism(Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women[J]. Fertil Steril, 2009, 91(2): 432-439.
  • 5DAELEMANS C, SMITS G, DE MAERTELAER V, et al. Pre- diction of severity of symptoms in iatrogenic ovarian hyperstimu- lation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism[J]. J Clin Endocrinol Metab, 2004, 89 (12): 6310-6315.
  • 6D'ALVA CB, SERAFINI P, MOTTA E. Absence of folli- cle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome[J]. Fertil Steril, 2005, 83: 1695-1699.
  • 7KERKELA E, SKOTTMAN H, FRIDEN B, et al. Exclusion of coding-region mutations in luteinizing hormone and follicle-stim- ulating hormone receptor genes as the cause of ovarian hyper- stimulation syndrome[J]. Fertile Steril, 2007, 87: 603-606.
  • 8MOHIYIDDEEN L, NARDO LG. Single-nucleotide polymor- phisms in the FSH receptor gene and ovarian performance: fu- ture role in IVF[J]. Hum Fertil (Camb), 2010, 13(2): 72-78.
  • 9KUIJPER EA, BLANKENSTEIN MA, LUTTIKHOF LJ, et al. Frequency distribution of polymorphisms in the FSH receptor gene in infertility patients of different ethnieity[J]. Reprod Biomed Online, 2011, 22 Suppl 1: S60-65.
  • 10LOUTRADIS D, VLISMAS A, DRAKAKIS P, et al. Pharmaco- genetics in ovarian stimulation-current concepts[J]. Ann NYAcad Sci, 2008, 1127: 10-19.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部